Alaska Blind Child Discovery

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Alaska Blind Child Discovery sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).

7 total trials 1 currently recruiting 6 completed upper quartile by trial count

Alaska Blind Child Discovery: 7 sponsored US clinical trials, 1 recruiting.

Alaska Blind Child Discovery sponsors 7 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 6 completed. The most-studied condition in this pipeline is Strabismus, with 1 trials.

Upper-quartile sponsor footprint

Alaska Blind Child Discovery sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

What is open in the Alaska Blind Child Discovery pipeline

1 recruiting of 7 indexed (14% open); 6 completed (86%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Strabismus (1 trial), 2 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Alaska Blind Child Discovery: open-pipeline peers nationwide

Peers matched on 7 registered trials and 14% open enrollment, not the therapeutic-area sidebar.

Alaska Blind Child Discovery sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01020304050 0%10%20%30%40% Total trials Recruiting share Alaska Blind Child Discovery3M4Life Research89bioAbbott Diagnostics DivisionAcademic and Community Cancer Research UnitedAdaptive BiotechnologiesAgelessRxAmerican College of Radiology
Alaska Blind Child Discovery sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Alaska Blind Child Discovery sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 7 trials (± recruiting share)

Sponsors near 14% open enrollment (± trial volume)

What to do with this Alaska Blind Child Discovery page

7 registered trials is a research-attention snapshot, not an endorsement of Alaska Blind Child Discovery or any single study.

  • 1 of Alaska Blind Child Discovery's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Strabismus is the condition Alaska Blind Child Discovery studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Strabismus trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Alaska Blind Child Discovery pipeline card: 7 registered trials from official public datasets.Report a data error.